It is found that aristolochic acid I accelerated liver tumorigenesis in ARID1A‐deficient context by impairing nucleotide excision repair and enhancing carcinogen bioactivation, revealing key mechanisms driving cancer development. This evidence concerns the gene ARID1A and cancer.